PUBLISHER: The Business Research Company | PRODUCT CODE: 1669491
PUBLISHER: The Business Research Company | PRODUCT CODE: 1669491
A clinical trial management system (CTMS) is a software system utilized by the biotechnology and pharmaceutical industries for the management of clinical trials in clinical research. It serves as a comprehensive solution to centralize, organize, and automate various aspects of the clinical trial process, facilitating efficient study planning, execution, monitoring, and reporting.
The primary types of clinical trial management systems include enterprise-based and site-based systems. An enterprise-based CTMS is a software solution implemented and operated across an entire organization or enterprise, providing a centralized platform for managing all clinical trials conducted by the organization. The components of a clinical trial management system encompass software, services, and hardware, delivered in cloud-based, web-based, and on-premises modes for use by pharmaceutical and biopharmaceutical companies, medical device manufacturers, clinical research organizations (CROs), and other relevant entities.
The clinical trials management system research report is one of a series of new reports from The Business Research Company that provides clinical trials management system market statistics, including the clinical trials management system's global market size, regional shares, competitors with a clinical trials management system market share, detailed clinical trials management system market segments, market trends and opportunities, and any further data you may need to thrive in the clinical trials management system. This clinical trials management system market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The clinical trial management system market size has grown rapidly in recent years. It will grow from $1.98 billion in 2024 to $2.25 billion in 2025 at a compound annual growth rate (CAGR) of 13.5%. The growth in the historic period can be attributed to increase in clinical trial complexity, growing globalization of clinical trials, rise in clinical trial volume, adoption of electronic data capture (etc), demand for cost and time-efficient trials
The clinical trial management system market size is expected to see rapid growth in the next few years. It will grow to $3.7 billion in 2029 at a compound annual growth rate (CAGR) of 13.2%. The growth in the forecast period can be attributed to emphasis on patient-centric clinical trials, adoption of risk-based monitoring, growth in precision medicine, introduction of adaptive trial designs, increased outsourcing of clinical trial operations, mobile health (mhealth) integration in clinical trials, implementation of cloud-based CTMS solutions, focus on data standardization and interoperability. Major trends in the forecast period include advances in information technology, real-time data access and management, integration of artificial intelligence in CTMS, utilization of blockchain for data security, collaboration between pharma companies and CROs.
The growth of the clinical trial management system market is anticipated to be driven by the increasing number of clinical trials. These trials involve research studies conducted on human participants to assess the safety, effectiveness, and potential benefits of new medical treatments, interventions, or drugs. Clinical Trials Management Systems (CTMS) are specialized software platforms designed to streamline and facilitate the management of these clinical trials. Notably, data from ClinicalTrials.gov, a component of the National Institutes of Health (NIH), revealed a rise in registered clinical trial studies from 399,499 in 2022 to 437,533 across all 50 states in the United States and 221 countries. Of these, 140,492 studies (31%) were registered in the U.S., and 241,498 studies (53%) were conducted in non-U.S. locations. Therefore, the increasing number of clinical trials is expected to propel the growth of the clinical trial management system market.
The growth of the clinical trial management system market is further expected to be boosted by the increasing healthcare expenditure. Healthcare expenditure refers to the total amount of money spent on healthcare goods and services within a specified time frame, encompassing spending by individuals, communities, or governments. As healthcare budgets expand, there is a corresponding increase in resources allocated to clinical research, resulting in a surge in the number of conducted clinical trials. This heightened demand for robust CTMS is driven by the need to manage the intricate logistics and data associated with these trials. According to the 2021-2030 National Health Expenditure (NHE) report by the Centers for Medicare & Medicaid Services, national health spending is projected to increase by an average of 5.1% annually between 2021 and 2030, reaching nearly $6.8 trillion. During the same period, Medicare spending is expected to rise at a 7.2% annual pace, while Medicaid spending will increase at a 5.6% annual rate. Thus, the increasing healthcare expenditure is a key driver of the growth of the clinical trial management system market.
A significant trend in the clinical trial management system market is the focus on technological advancements by major companies. These companies are actively involved in developing innovative product technologies to strengthen their market positions. For instance, Saama Technologies, Inc., a U.S.-based provider of clinical development software and services, launched a unified platform of Software as a Service (SaaS)-based products in June 2023. This platform complements existing artificial intelligence and machine learning-based solutions, facilitating faster clinical development and commercialization. It automates critical clinical trial management processes, reducing query generation times by up to 90% and achieving substantial time savings in study data transformation and analysis. The platform provides a comprehensive view of trial operations and patient progress in a single location.
Major companies in the clinical trial management system market are prioritizing the development of technologically innovative solutions, such as clinical trial technology platforms, to streamline trial processes, improve data accuracy, and ensure regulatory compliance. A clinical trial technology platform is a comprehensive digital ecosystem designed to manage and simplify the complex processes involved in clinical trials. For example, in June 2024, IQVIA, a US-based health information technology company, launched the One Home for Sites platform, a holistic technology solution intended to streamline clinical trial management by integrating multiple applications into a single sign-on dashboard. This platform alleviates the administrative burdens faced by clinical research sites, enabling staff to concentrate more on patient care and recruitment while efficiently managing multiple trials. The platform aims to enhance operational efficiency, accelerate trial processes, and ultimately increase the availability of new treatments for patients.
In July 2023, RealTime Software Solutions, LLC, a US-based company and leading provider of cloud-based software solutions, acquired Devana Solutions, LLC, for an undisclosed amount. This acquisition is strategically aimed at leveraging complementary technologies to enhance clinical trial processes, improve operational efficiencies, and better support both researchers and participants. Devana Solutions, LLC is a US-based cloud software company specializing in clinical trial workflow and analytics.
Major companies operating in the clinical trial management system market include International Business Machines Corporation, Oracle Corporation, Cognizant Technology Solutions India Private Limited, Laboratory Corporation of America Holdings, Wipro Limited, Veeva Systems Inc, Medidata Solutions, BioClinica Inc., Calyx, Clario, Advarra Inc, ArisGlobal LLC, MasterControl Solutions Inc., Medrio Inc., Anju Software Inc., Forte Research System Inc, Cmed Clinical Services, OmniComm Systems Inc., MedNet Solutions Inc., DSG Inc., eClinical Solutions LLC, Bioclinical Partners (BCP), Flex Databases, DataTrak International Inc., OpenClinica LLC, SimpleTrials, PHARMASEAL International Ltd, Dacima Software Inc., RealTime Software Solutions LLC
North America was the largest region in the Asia Pacific market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the clinical trial management system market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The countries covered in the clinical trial management system market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.
The clinical trials management system market consists of revenues earned by entities by providing Web-based clinical trials management system, End-to-end clinical trials management system, Integrated clinical trials management system, and Cloud-based clinical trials management system. The market value includes the value of related goods sold by the service provider or included within the service offering. The clinical trials management system market also includes sales of clinical trial analytics tools, scanners, printers, and electronic data capture devices that are used in providing clinical trials management services. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Clinical Trial Management System Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on clinical trial management system market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for clinical trial management system ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The clinical trial management system market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.